Search alternatives:
feature optimization » resource optimization (Expand Search), feature elimination (Expand Search), structure optimization (Expand Search)
based optimization » whale optimization (Expand Search)
binary each » binary health (Expand Search)
free based » tree based (Expand Search), arene based (Expand Search)
feature optimization » resource optimization (Expand Search), feature elimination (Expand Search), structure optimization (Expand Search)
based optimization » whale optimization (Expand Search)
binary each » binary health (Expand Search)
free based » tree based (Expand Search), arene based (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
<i>hi</i>PRS algorithm process flow.
Published 2023“…<b>(C)</b> The whole training data is then scanned, searching for these sequences and deriving a re-encoded dataset where interaction terms are binary features (i.e., 1 if sequence <i>i</i> is observed in <i>j</i>-th patient genotype, 0 otherwise). …”
-
11
-
12
-
13
Overview of study assessments of the trial.
Published 2024“…A QPOP-guided treatment selection algorithm will then be used to select the most appropriate drug combination. …”
-
14
-
15
-
16
-
17
Data Sheet 4_Identification of a signature gene set for oxaliplatin sensitivity prediction in colorectal cancer.pdf
Published 2025“…Background<p>Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Oxaliplatin-based chemotherapy is a cornerstone of treatment for many CRC patients; however, the development of chemoresistance severely limits its therapeutic efficacy and remains a major clinical challenge. …”
-
18
Data Sheet 1_Identification of a signature gene set for oxaliplatin sensitivity prediction in colorectal cancer.pdf
Published 2025“…Background<p>Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Oxaliplatin-based chemotherapy is a cornerstone of treatment for many CRC patients; however, the development of chemoresistance severely limits its therapeutic efficacy and remains a major clinical challenge. …”
-
19
Table 1_Identification of a signature gene set for oxaliplatin sensitivity prediction in colorectal cancer.xlsx
Published 2025“…Background<p>Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Oxaliplatin-based chemotherapy is a cornerstone of treatment for many CRC patients; however, the development of chemoresistance severely limits its therapeutic efficacy and remains a major clinical challenge. …”
-
20
Data Sheet 2_Identification of a signature gene set for oxaliplatin sensitivity prediction in colorectal cancer.pdf
Published 2025“…Background<p>Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Oxaliplatin-based chemotherapy is a cornerstone of treatment for many CRC patients; however, the development of chemoresistance severely limits its therapeutic efficacy and remains a major clinical challenge. …”